Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model

被引：0
|
作者：
Bhol, Kailash [1 ]
Erlich, Emma [1 ]
Lemos, Brenda [1 ]
Tracey, Daniel [1 ]
Hartman, Deborah [1 ]
Fox, Barbara [1 ]
机构：
[1] Avaxia Biol Inc, Lexington, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01810
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1810
引用
收藏
页码：S545 / S546
页数：2
相关论文
共 50 条
  • [21] Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease
    Ha, Christina
    Mathur, Jagrati
    Kornbluth, Asher
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (04) : 497 - 505
  • [22] PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
    Costable, Nicholas J.
    Borman, Zachary A.
    Phan, Becky L.
    Ji, Jiayi
    Dubinsky, Marla
    Ungaro, Ryan C.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S468 - S469
  • [23] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Costable, Nicholas J.
    Borman, Zachary A.
    Ji, Jiayi
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2480 - 2484
  • [24] Characterization of Neutralizing Anti-Drug Antibody Response in Patients With Loss of Response to Anti-TNF Therapy
    Hauenstein, Scott
    Salbato, Jared
    Lockton, Steven
    Singh, Sharat
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S418 - S418
  • [25] Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
    Hamilton, R.
    Shields, S.
    MacDonald, J.
    Dunlop, A.
    Perry, M.
    McGucken, A.
    Gribben, E.
    Galloway, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S249 - S250
  • [26] Immunogenicity, the elephant in the room. Comment on “Drug levels, anti-drug antibodies and clinical efficacy of the anti-TNFα biologics in rheumatic diseases”
    John Pixley
    [J]. Clinical Rheumatology, 2013, 32 : 1413 - 1413
  • [27] Immunogenicity, the elephant in the room. Comment on "Drug levels, anti-drug antibodies and clinical efficacy of the anti-TNFα biologics in rheumatic diseases"
    Pixley, John
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (10) : 1413 - 1413
  • [28] ANTI-DRUG ANTIBODIES TO INFLIXIMAB: A COMPARISON OF FREE ANTI-DRUG ANTIBODY MEASUREMENT
    Hamilton, Rhona
    Shields, Stephanie
    Macdonald, Jonathan
    Dunlop, Allan
    Perry, Martin
    McGucken, Andrew
    Gribben, Elain
    Galloway, Peter
    [J]. GUT, 2021, 70 : A121 - A121
  • [29] Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    [J]. CURRENT DRUG METABOLISM, 2011, 12 (06) : 594 - 598
  • [30] Anti-drug antibodies against anti-TNF in patients with inflammatory bowel disease: an evaluation of possible strategies
    Anjie, Suzanne I.
    Hanzel, Jurij
    Gecse, Krisztina B.
    D'Haens, Geert R.
    Brandse, Johannan F.
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (02) : 169 - 175
12345